R&D Collaboration Agreement definition

R&D Collaboration Agreement means the Research and Development Collaboration Agreement, dated as of the date of this Agreement, between TimkenSteel and Timken, as may be amended or modified from time to time.
R&D Collaboration Agreement means that certain Collaboration Agreement between Roche Ltd and Hxxxxxxx-Xx Xxxxx, Inc., on the one hand, and FMI, on the other hand, which was entered into pursuant to and concurrently with the Transaction Agreement, and relates to the use of FMI’s molecular information platform and the development of immunotherapy, circulating tumor DNA and companion diagnostics platforms.
R&D Collaboration Agreement means the form of R&D Collaboration Agreement attached as Exhibit 8 hereto.

Examples of R&D Collaboration Agreement in a sentence

  • The provisions of Sections 19.2 and 19.3 of the R&D Collaboration Agreement are incorporated herein and shall apply mutatis mutandis.

  • The responsibilities of the Joint Research and Development Committee (“JRDC”) and Joint Management Committee (“JMC”) established by the R&D Collaboration Agreement shall be extended to apply to the IVD Collaboration.

  • In furtherance of the foregoing, the provisions of Article 6 of the R&D Collaboration Agreement are incorporated herein and shall apply mutatis mutandis; provided, however, that Sections 6.1.2, 6.1.5.1, 6.1.5.2, 6.1.7, 6.3, and 6.7 of the R&D Collaboration Agreement shall not apply to this Agreement or any activities under the IVD Collaboration.

  • Separate and apart from the R&D Collaboration Agreement, the parties are carrying out limited work, which would continue and be paid for separately regardless of whether the Investment closes and the R&D Collaboration Agreement becomes effective.

  • However, certain provisions of the R&D Collaboration Agreement may remain in effect after such initial five-year term so long as Purchaser and its affiliates own at least a majority of the outstanding Shares.

  • Pursuant to the R&D Collaboration Agreement, FMI and Roche will collaborate on multiple programs related to the use and development of products and services for use in molecular information, immunotherapy, circulating tumor DNA, and companion diagnostics.

  • Either FMI or Roche may terminate the R&D Collaboration Agreement in the event of a breach of the agreement by the other party.

  • Pursuant to the Ex-U.S. Commercialization Agreement, Roche will have the right to commercialize FMI’s existing clinical diagnostic testing products, including FoundationOne and FoundationOne Heme, any clinical diagnostic products developed under the R&D Collaboration Agreement and any other products upon mutual agreement.

  • The initial term of the R&D Collaboration Agreement is five years.

Related to R&D Collaboration Agreement

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Collaborative agreement means a voluntary, written, or electronic arrangement between one

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.

  • Manufacturing Agreement has the meaning set forth in Section 2.6.

  • Research Agreement means a new written contract, grant or cooperative agreement entered into between a person and a college or research corporation for the performance of qualified research; however, all qualified research costs generating a rebate must be spent by the college or research corporation on qualified research undertaken according to a research agreement.

  • Development Agreement has the meaning set forth in the Recitals.

  • Collaboration Know-How means all Know-How and Materials discovered, created, conceived, developed or reduced to practice in the course of performing activities under the Collaboration Program (whether solely by one Party or jointly by the Parties, in each case with their Affiliates or any Third Parties or any employees, consultants or agents of any of the foregoing which perform activities under the Collaboration Program).

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • Collaboration Term has the meaning specified in Section 2.1.2 hereof.

  • Exclusivity Agreement , in relation to land, means an agreement, by the owner or a lessee of the land, not to permit any person (other than the persons identified in the agreement) to construct a solar pv station on the land;”;

  • Supply Agreement has the meaning set forth in Section 7.1.

  • Joint Development Agreement has the meaning provided in Section 5.3.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Collaboration has the meaning set forth in Section 2.1.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Royalty Agreement means the amended royalty agreement between the Partnership, Vermilion, 1209963 Alberta Ltd. and the Trust dated January 22, 2003 providing for the creation of the Royalty;

  • Pharmacovigilance Agreement has the meaning set forth in Section 4.3.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Research License means a nontransferable, nonexclusive license to make and to use the Licensed Products or the Licensed Processes as defined by the Licensed Patent Rights for purposes of research and not for purposes of commercial manufacture or distribution or in lieu of purchase.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Clinical Supply Agreement shall have the meaning set forth in Section 7.2.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Software License Agreement means the Motorola Software License Agreement (Exhibit A).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).